{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T06:05:45Z","timestamp":1792044345461,"version":"4.4.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T00:00:00Z","timestamp":1592784000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T00:00:00Z","timestamp":1592784000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81972339"],"award-info":[{"award-number":["81972339"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81671371"],"award-info":[{"award-number":["81671371"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["91853128"],"award-info":[{"award-number":["91853128"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31470770"],"award-info":[{"award-number":["31470770"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81525019"],"award-info":[{"award-number":["81525019"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011470","name":"Shanghai Municipal Science and Technology Commission","doi-asserted-by":"publisher","award":["18XD1403400"],"award-info":[{"award-number":["18XD1403400"]}],"id":[{"id":"10.13039\/501100011470","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010098","name":"Shanghai Association for Science and Technology","doi-asserted-by":"publisher","award":["19140903500"],"award-info":[{"award-number":["19140903500"]}],"id":[{"id":"10.13039\/100010098","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","award":["2019YFA082103"],"award-info":[{"award-number":["2019YFA082103"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","award":["2018ZX10101004"],"award-info":[{"award-number":["2018ZX10101004"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007156","name":"Innovation and Technology Commission - Hong Kong","doi-asserted-by":"publisher","award":["NYKFKT2019006"],"award-info":[{"award-number":["NYKFKT2019006"]}],"id":[{"id":"10.13039\/501100007156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011332","name":"University of Chinese Academy of Sciences","doi-asserted-by":"publisher","award":["XDB19000000"],"award-info":[{"award-number":["XDB19000000"]}],"id":[{"id":"10.13039\/501100011332","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011332","name":"University of Chinese Academy of Sciences","doi-asserted-by":"publisher","award":["XDA12040323"],"award-info":[{"award-number":["XDA12040323"]}],"id":[{"id":"10.13039\/501100011332","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neuropathol"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1007\/s00401-020-02180-4","type":"journal-article","created":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T05:02:46Z","timestamp":1592802166000},"page":"377-396","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["The KBTBD6\/7-DRD2 axis regulates pituitary adenoma sensitivity to dopamine agonist treatment"],"prefix":"10.1007","volume":"140","author":[{"given":"Yan Ting","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei Ting","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong Zhi","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan Qun","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo Han","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuo Hui","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying Jie","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronggui","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1611-8228","authenticated-orcid":false,"given":"Zhe Bao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,22]]},"reference":[{"key":"2180_CR1","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1210\/en.2010-0886","volume":"152","author":"H Al-Azzawi","year":"2011","unstructured":"Al-Azzawi H, Yacqub-Usman K, Richardson A, Hofland LJ, Clayton RN, Farrell WE (2011) Reversal of endogenous dopamine receptor silencing in pituitary cells augments receptor-mediated apoptosis. Endocrinology 152:364\u2013373. https:\/\/doi.org\/10.1210\/en.2010-0886","journal-title":"Endocrinology"},{"key":"2180_CR2","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1111\/j.1601-183X.2006.00290.x","volume":"6","author":"D Bartr\u00e9s-Faz","year":"2007","unstructured":"Bartr\u00e9s-Faz D, Mart\u00ed MJ, Junqu\u00e9 C, Sol\u00e9-Padull\u00e9s C, Ezquerra M, Bralten LBC et al (2007) Increased cerebral activity in Parkinson\u2019s disease patients carrying the DRD2 TaqIA A1 allele during a demanding motor task: a compensatory mechanism? Genes Brain Behav 6:588\u2013592. https:\/\/doi.org\/10.1111\/j.1601-183X.2006.00290.x","journal-title":"Genes Brain Behav"},{"key":"2180_CR3","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1124\/pr.110.002642","volume":"63","author":"JM Beaulieu","year":"2011","unstructured":"Beaulieu JM, Gainetdinov RR (2011) The physiology, signaling, and pharmacology of dopamine receptors. Pharmacol Rev 63:182\u2013217. https:\/\/doi.org\/10.1124\/pr.110.002642","journal-title":"Pharmacol Rev"},{"key":"2180_CR4","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1210\/edrv-13-2-220","volume":"13","author":"JS Bevan","year":"1992","unstructured":"Bevan JS, Webster J, Burke CW, Scanlon MF (1992) Dopamine agonists and pituitary tumor shrinkage. Endocr Rev 13:220\u2013240. https:\/\/doi.org\/10.1210\/edrv-13-2-220","journal-title":"Endocr Rev"},{"key":"2180_CR5","doi-asserted-by":"publisher","first-page":"439","DOI":"10.3181\/0704-RM-94","volume":"233","author":"S Bondioni","year":"2008","unstructured":"Bondioni S, Angioni AR, Corbetta S, Locatelli M, Ferrero S, Ferrante E et al (2008) Effect of 9-cis retinoic acid on dopamine D2 receptor expression in pituitary adenoma cells. Exp Biol Med 233:439\u2013446. https:\/\/doi.org\/10.3181\/0704-RM-94","journal-title":"Exp Biol Med"},{"key":"2180_CR6","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1159\/000126764","volume":"60","author":"L Caccavelli","year":"1994","unstructured":"Caccavelli L, Feron F, Morange I, Rouer E, Benarous R, Dewailly D et al (1994) Decreased expression of the two D2 dopamine receptor isoforms in bromocriptine- resistant prolactinomas. Neuroendocrinology 60:314\u2013322. https:\/\/doi.org\/10.1159\/000126764","journal-title":"Neuroendocrinology"},{"key":"2180_CR7","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1111\/j.1365-2265.2006.02562.x","volume":"65","author":"FF Casanueva","year":"2006","unstructured":"Casanueva FF, Molitch ME, Schlechte JA, Abs R, Bonert V, Bronstein MD et al (2006) Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas. Clin Endocrinol 65:265\u2013273. https:\/\/doi.org\/10.1111\/j.1365-2265.2006.02562.x","journal-title":"Clin Endocrinol"},{"key":"2180_CR8","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/nrendo.2011.37","volume":"7","author":"A Colao","year":"2011","unstructured":"Colao A, Savastano S (2011) Medical treatment of prolactinomas. Nat Rev Endocrinol 7:267\u2013278. https:\/\/doi.org\/10.1038\/nrendo.2011.37","journal-title":"Nat Rev Endocrinol"},{"key":"2180_CR9","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/0376-8716(94)90105-8","volume":"35","author":"DE Comings","year":"1994","unstructured":"Comings DE (1994) Genetic factors in substance abuse based on studies of Tourette Syndrome and ADHD probands and relatives. II. Alcohol abuse. Drug Alcohol Depend 35:17\u201324.\u00a0https:\/\/doi.org\/10.1016\/0376-8716(94)90105-8","journal-title":"Drug Alcohol Depend"},{"key":"2180_CR10","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.mce.2012.01.026","volume":"355","author":"T Cuny","year":"2012","unstructured":"Cuny T, Mohamed A, Graillon T, Roche C, Defilles C, Germanetti AL et al (2012) Somatostatin receptor sst2 gene transfer in human prolactinomas in vitro: impact on sensitivity to dopamine, somatostatin and dopastatin, in the control of prolactin secretion. Mol Cell Endocrinol 355:106\u2013113. https:\/\/doi.org\/10.1016\/j.mce.2012.01.026","journal-title":"Mol Cell Endocrinol"},{"key":"2180_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05214-4","author":"S Duvarci","year":"2018","unstructured":"Duvarci S, Simpson EH, Schneider G, Kandel ER, Roeper J, Sigurdsson T (2018) Impaired recruitment of dopamine neurons during working memory in mice with striatal D2 receptor overexpression. Nat Commun. https:\/\/doi.org\/10.1038\/s41467-018-05214-4","journal-title":"Nat Commun"},{"key":"2180_CR12","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1158\/1535-7163.MCT-15-0030","volume":"14","author":"L Fang","year":"2015","unstructured":"Fang L, Yang Z, Zhou J, Tung JY, Hsiao CD, Wang L et al (2015) Circadian clock gene CRY2 degradation is involved in chemoresistance of colorectal cancer. Mol Cancer Ther 14:1476\u20131487. https:\/\/doi.org\/10.1158\/1535-7163.MCT-15-0030","journal-title":"Mol Cancer Ther"},{"key":"2180_CR13","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1038\/npp.2015.11","volume":"40","author":"EF Gallo","year":"2015","unstructured":"Gallo EF, Salling MC, Feng B, Mor\u00f3n JA, Harrison NL, Javitch JA et al (2015) Upregulation of dopamine D2 receptors in the nucleus accumbens indirect pathway increases locomotion but does not reduce alcohol consumption. Neuropsychopharmacol 40:1609\u20131618. https:\/\/doi.org\/10.1038\/npp.2015.11","journal-title":"Neuropsychopharmacol"},{"key":"2180_CR14","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/j.molcel.2014.12.040","volume":"57","author":"HM Genau","year":"2015","unstructured":"Genau HM, Huber J, Baschieri F, Akutsu M, D\u00f6tsch V, Farhan H et al (2015) CUL3-KBTBD6\/KBTBD7Ubiquitin ligase cooperates with GABARAP proteins to spatially restrict TIAM1-RAC1 signaling. Mol Cell 57:995\u20131010. https:\/\/doi.org\/10.1016\/j.molcel.2014.12.040","journal-title":"Mol Cell"},{"key":"2180_CR15","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1210\/er.2005-9998","volume":"27","author":"MP Gillam","year":"2006","unstructured":"Gillam MP, Molitch ME, Lombardi G, Colao A (2006) Advances in the treatment of prolactinomas. Endocr Rev 27:485\u2013534. https:\/\/doi.org\/10.1210\/er.2005-9998","journal-title":"Endocr Rev"},{"key":"2180_CR16","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/s41467-017-00357-2","volume":"8","author":"A Godbole","year":"2017","unstructured":"Godbole A, Lyga S, Lohse MJ, Calebiro D (2017) Internalized TSH receptors en route to the TGN induce local Gs-protein signaling and gene transcription. Nat Commun 8:443. https:\/\/doi.org\/10.1038\/s41467-017-00357-2","journal-title":"Nat Commun"},{"key":"2180_CR17","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/387296a0","volume":"387","author":"Y Haupt","year":"1997","unstructured":"Haupt Y, Maya R, Kazaz A, Oren M (1997) Mdm2 promotes the rapid degradation of p53. Nature 387:296\u2013299. https:\/\/doi.org\/10.1038\/387296a0","journal-title":"Nature"},{"key":"2180_CR18","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1038\/nature07960","volume":"458","author":"D Hoeller","year":"2009","unstructured":"Hoeller D, Dikic I (2009) Targeting the ubiquitin system in cancer therapy. Nature 458:438\u2013444. https:\/\/doi.org\/10.1038\/nature07960","journal-title":"Nature"},{"key":"2180_CR19","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1158\/2159-8290.CD-13-0146","volume":"3","author":"PE Hollstein","year":"2013","unstructured":"Hollstein PE, Cichowski K (2013) Identifying the ubiquitin ligase complex that regulates the NF1 tumor suppressor and Ras. Cancer Discov 3:880\u2013893. https:\/\/doi.org\/10.1158\/2159-8290.CD-13-0146","journal-title":"Cancer Discov"},{"key":"2180_CR20","doi-asserted-by":"publisher","first-page":"17","DOI":"10.5483\/BMBRep.2010.43.1.017","volume":"43","author":"J Hu","year":"2010","unstructured":"Hu J, Yuan W, Tang M, Wang Y, Fan X, Mo X et al (2010) KBTBD7, a novel human BTB-kelch protein, activates transcriptional activities of SRE and AP-1. Bmb Rep 43:17\u201322. https:\/\/doi.org\/10.5483\/BMBRep.2010.43.1.017","journal-title":"Bmb Rep"},{"key":"2180_CR21","doi-asserted-by":"publisher","first-page":"16076","DOI":"10.1074\/jbc.M500109200","volume":"280","author":"C Jacob","year":"2005","unstructured":"Jacob C, Cottrell GS, Gehringer D, Schmidlin F, Grady EF, Bunnett NW (2005) c-Cbl mediates ubiquitination, degradation, and down-regulation of human protease-activated receptor 2. J Biol Chem 280:16076\u201316087. https:\/\/doi.org\/10.1074\/jbc.M500109200","journal-title":"J Biol Chem"},{"key":"2180_CR22","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1091\/mbc.E02-08-0532","volume":"14","author":"X Jiang","year":"2003","unstructured":"Jiang X, Huang F, Marusyk A, Sorkin A (2003) Grb2 regulates internalization of EGF receptors through clathrin-coated pits. Mol Biol Cell 14:858\u2013870. https:\/\/doi.org\/10.1091\/mbc.E02-08-0532","journal-title":"Mol Biol Cell"},{"key":"2180_CR23","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/277093a0","volume":"277","author":"JW Kebabian","year":"1979","unstructured":"Kebabian JW, Calne DB (1979) Multiple receptors for dopamine. Nature 277:93\u201396. https:\/\/doi.org\/10.1038\/277093a0","journal-title":"Nature"},{"key":"2180_CR24","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.neuron.2006.01.023","volume":"49","author":"C Kellendonk","year":"2006","unstructured":"Kellendonk C, Simpson EH, Polan HJ, Malleret G, Vronskaya S, Winiger V et al (2006) Transient and selective overexpression of dopamine D2 receptors in the striatum causes persistent abnormalities in prefrontal cortex functioning. Neuron 49:603\u2013615. https:\/\/doi.org\/10.1016\/j.neuron.2006.01.023","journal-title":"Neuron"},{"key":"2180_CR25","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1080\/10799890802379410","volume":"28","author":"OJ Kim","year":"2008","unstructured":"Kim OJ (2008) A single mutation at lysine 241 alters expression and trafficking of the D2 dopamine receptor. J Recept Signal Transduct Res 28:453\u2013464. https:\/\/doi.org\/10.1080\/10799890802379410","journal-title":"J Recept Signal Transduct Res"},{"key":"2180_CR26","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1523\/JNEUROSCI.4287-10.2011","volume":"31","author":"PF Kramer","year":"2011","unstructured":"Kramer PF, Christensen CH, Hazelwood LA, Dobi A, Bock R, Sibley DR et al (2011) Dopamine D2 receptor overexpression alters behavior and physiology in Drd2-EGFP mice. J Neurosci 31:126\u2013132. https:\/\/doi.org\/10.1523\/JNEUROSCI.4287-10.2011","journal-title":"J Neurosci"},{"key":"2180_CR27","doi-asserted-by":"publisher","first-page":"16906","DOI":"10.1073\/pnas.0604994103","volume":"103","author":"WS Lai","year":"2006","unstructured":"Lai WS, Xu B, Westphal KGC, Paterlini M, Olivier B, Pavlidis P et al (2006) Akt1 deficiency affects neuronal morphology and predisposes to abnormalities in prefrontal cortex functioning. Proc Natl Acad Sci USA 103:16906\u201316911. https:\/\/doi.org\/10.1073\/pnas.0604994103","journal-title":"Proc Natl Acad Sci USA"},{"key":"2180_CR28","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/j.molcel.2016.08.009","volume":"63","author":"HJ Lee","year":"2016","unstructured":"Lee HJ, Li CF, Ruan D, Powers S, Thompson PA, Frohman MA et al (2016) The DNA Damage transducer RNF8 facilitates cancer chemoresistance and progression through twist activation. Mol Cell 63:1021\u20131033. https:\/\/doi.org\/10.1016\/j.molcel.2016.08.009","journal-title":"Mol Cell"},{"key":"2180_CR29","doi-asserted-by":"publisher","first-page":"4565","DOI":"10.1210\/jc.2013-2350","volume":"98","author":"RS Legro","year":"2013","unstructured":"Legro RS, Arslanian SA, Ehrmann DA, Hoeger KM, Murad MH, Pasquali R et al (2013) Diagnosis and treatment of polycystic ovary syndrome: an endocrine society clinical practice guideline. J Clin Endocr Metab 98:4565\u20134592. https:\/\/doi.org\/10.1210\/jc.2013-2350","journal-title":"J Clin Endocr Metab"},{"key":"2180_CR30","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/ejn.14219","volume":"51","author":"J LeSauter","year":"2020","unstructured":"LeSauter J, Balsam PD, Simpson EH, Silver R (2020) Overexpression of striatal D2 receptors reduces motivation thereby decreasing food anticipatory activity. Eur J Neurosci 51:71\u201381. https:\/\/doi.org\/10.1111\/ejn.14219","journal-title":"Eur J Neurosci"},{"key":"2180_CR31","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.mce.2013.10.021","volume":"382","author":"Q Li","year":"2014","unstructured":"Li Q, Su Z, Liu J, Cai L, Lu J, Lin S et al (2014) Dopamine receptor D2S gene transfer improves the sensitivity of GH3 rat pituitary adenoma cells to bromocriptine. Mol Cell Endocrinol 382:377\u2013384. https:\/\/doi.org\/10.1016\/j.mce.2013.10.021","journal-title":"Mol Cell Endocrinol"},{"key":"2180_CR32","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1172\/JCI75821","volume":"125","author":"Z Li","year":"2015","unstructured":"Li Z, Younger K, Gartenhaus R, Joseph AM, Hu F, Baer MR et al (2015) Inhibition of IRAK1\/4 sensitizes T cell acute lymphoblastic leukemia to chemotherapies. J Clin Invest 125:1081\u20131097. https:\/\/doi.org\/10.1172\/JCI75821","journal-title":"J Clin Invest"},{"key":"2180_CR33","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.ccr.2014.05.015","volume":"26","author":"Z Liu","year":"2014","unstructured":"Liu Z, Chen P, Gao H, Gu Y, Yang J, Peng H et al (2014) Ubiquitylation of autophagy receptor optineurin by HACE1 activates selective autophagy for tumor suppression. Cancer Cell 26:106\u2013120. https:\/\/doi.org\/10.1016\/j.ccr.2014.05.015","journal-title":"Cancer Cell"},{"key":"2180_CR34","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.bbrc.2009.06.045","volume":"386","author":"AV Makeyev","year":"2009","unstructured":"Makeyev AV, Bayarsaihan D (2009) New TFII-I family target genes involved in embryonic development. Biochem Biophys Res Commun 386:554\u2013558. https:\/\/doi.org\/10.1016\/j.bbrc.2009.06.045","journal-title":"Biochem Biophys Res Commun"},{"key":"2180_CR35","doi-asserted-by":"publisher","first-page":"45509","DOI":"10.1074\/jbc.C100527200","volume":"276","author":"A Marchese","year":"2001","unstructured":"Marchese A, Benovic JL (2001) Agonist-promoted ubiquitination of the G protein-coupled receptor CXCR4 mediates lysosomal sorting. J Biol Chem 276:45509\u201345512. https:\/\/doi.org\/10.1074\/jbc.C100527200","journal-title":"J Biol Chem"},{"key":"2180_CR36","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S1534-5807(03)00321-6","volume":"5","author":"A Marchese","year":"2003","unstructured":"Marchese A, Raiborg C, Santini F, Keen JH, Stenmark H, Benovic JL (2003) The E3 ubiquitin ligase AIP4 mediates ubiquitination and sorting of the G protein-coupled receptor CXCR4. Dev Cell 5:709\u2013722. https:\/\/doi.org\/10.1016\/S1534-5807(03)00321-6","journal-title":"Dev Cell"},{"key":"2180_CR37","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1152\/physrev.1998.78.1.189","volume":"78","author":"C Missale","year":"1998","unstructured":"Missale C, Russel Nash S, Robinson SW, Jaber M, Caron MG (1998) Dopamine receptors: from structure to function. Physiol Rev 78:189\u2013225. https:\/\/doi.org\/10.1152\/physrev.1998.78.1.189","journal-title":"Physiol Rev"},{"key":"2180_CR38","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1023\/a:1022375429083","volume":"5","author":"ME Molitch","year":"2002","unstructured":"Molitch ME (2002) Medical management of prolactin-secreting pituitary adenomas. Pituitary 5:55\u201365. https:\/\/doi.org\/10.1023\/a:1022375429083","journal-title":"Pituitary"},{"key":"2180_CR39","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s11102-005-5085-2","volume":"8","author":"ME Molitch","year":"2005","unstructured":"Molitch ME (2005) Pharmacologic resistance in prolactinoma patients. Pituitary 8:43\u201352. https:\/\/doi.org\/10.1007\/s11102-005-5085-2","journal-title":"Pituitary"},{"key":"2180_CR40","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1056\/NEJMoa1516282","volume":"374","author":"P Moreau","year":"2016","unstructured":"Moreau P, Masszi T, Grzasko N, Bahlis NJ, Hansson M, Pour L et al (2016) Oral Ixazomib, lenalidomide, and dexamethasone for multiple myeloma. N Engl J Med 374:1621\u20131634. https:\/\/doi.org\/10.1056\/NEJMoa1516282","journal-title":"N Engl J Med"},{"key":"2180_CR41","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1056\/NEJMoa1606038","volume":"375","author":"A Palumbo","year":"2016","unstructured":"Palumbo A, Chanan-Khan A, Weisel K, Nooka AK, Masszi T, Beksac M et al (2016) Daratumumab, bortezomib, and dexamethasone for multiple myeloma. N Engl J Med 375:754\u2013766. https:\/\/doi.org\/10.1056\/NEJMoa1606038","journal-title":"N Engl J Med"},{"key":"2180_CR42","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1159\/000156116","volume":"89","author":"VQ Passos","year":"2009","unstructured":"Passos VQ, Fortes MAHZ, Giannella-Neto D, Bronstein MD (2009) Genes differentially expressed in prolactinomas responsive and resistant to dopamine agonists. Neuroendocrinology 89:163\u2013170. https:\/\/doi.org\/10.1159\/000156116","journal-title":"Neuroendocrinology"},{"key":"2180_CR43","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/cr.2017.40","volume":"27","author":"H Peng","year":"2017","unstructured":"Peng H, Yang J, Li G, You Q, Han W, Li T et al (2017) Ubiquitylation of p62\/sequestosome1 activates its autophagy receptor function and controls selective autophagy upon ubiquitin stress. Cell Res 27:657\u2013674. https:\/\/doi.org\/10.1038\/cr.2017.40","journal-title":"Cell Res"},{"key":"2180_CR44","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1097\/00001756-199904260-00018","volume":"10","author":"V Popendikyte","year":"1999","unstructured":"Popendikyte V, Laurinavicius A, Paterson AD, Macciardi F, Kennedy JL, Petronis A (1999) DNA methylation at the putative promoter region of the human dopamine D2 receptor gene. NeuroReport 10:1249\u20131255. https:\/\/doi.org\/10.1097\/00001756-199904260-00018","journal-title":"NeuroReport"},{"key":"2180_CR45","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.1056\/NEJMoa043445","volume":"352","author":"PG Richardson","year":"2005","unstructured":"Richardson PG, Sonneveld P, Schuster MW, Irwin D, Stadtmauer EA, Facon T et al (2005) Bortezomib or high-dose dexamethasone for relapsed multiple myeloma. N Engl J Med 352:2487\u20132498. https:\/\/doi.org\/10.1056\/NEJMoa043445","journal-title":"N Engl J Med"},{"key":"2180_CR46","doi-asserted-by":"publisher","first-page":"11083","DOI":"10.1074\/jbc.M708473200","volume":"283","author":"P Rondou","year":"2008","unstructured":"Rondou P, Haegeman G, Vanhoenacker P, Van Craenenbroeck K (2008) BTB protein KLHL12 targets the dopamine D4 receptor for ubiquitination by a Cul3-based E3 ligase. J Biol Chem 283:11083\u201311096. https:\/\/doi.org\/10.1074\/jbc.M708473200","journal-title":"J Biol Chem"},{"key":"2180_CR47","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1016\/j.cellsig.2010.01.014","volume":"22","author":"P Rondou","year":"2010","unstructured":"Rondou P, Skieterska K, Packeu A, Lintermans B, Vanhoenacker P, Vauquelin G et al (2010) KLHL12-mediated ubiquitination of the dopamine D4 receptor does not target the receptor for degradation. Cell Signal 22:900\u2013913. https:\/\/doi.org\/10.1016\/j.cellsig.2010.01.014","journal-title":"Cell Signal"},{"key":"2180_CR48","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1126\/science.1063866","volume":"294","author":"SK Shenoy","year":"2001","unstructured":"Shenoy SK, McDonald PH, Kohout TA, Lefkowitz RJ (2001) Regulation of receptor fate by ubiquitination of activated \u03b22-adrenergic receptor and \u03b2-arrestin. Science 294:1307\u20131313. https:\/\/doi.org\/10.1126\/science.1063866","journal-title":"Science"},{"key":"2180_CR49","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/0165-6147(92)90025-2","volume":"13","author":"DR Sibley","year":"1992","unstructured":"Sibley DR, Monsma FJ (1992) Molecular biology of dopamine receptors. Trends Pharmacol Sci 13:61\u201369.\u00a0https:\/\/doi.org\/10.1016\/0165-6147(92)90025-2","journal-title":"Trends Pharmacol Sci"},{"key":"2180_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/srep33233","author":"A Tabor","year":"2016","unstructured":"Tabor A, Weisenburger S, Banerjee A, Purkayastha N, Kaindl JM, H\u00fcbner H et al (2016) Visualization and ligand-induced modulation of dopamine receptor dimerization at the single molecule level. Sci Rep UK. https:\/\/doi.org\/10.1038\/srep33233","journal-title":"Sci Rep UK"},{"key":"2180_CR51","doi-asserted-by":"publisher","first-page":"3043","DOI":"10.1523\/JNEUROSCI.5689-09.2010","volume":"30","author":"H Takahashi","year":"2010","unstructured":"Takahashi H, Takano H, Kodaka F, Arakawa R, Yamada M, Otsuka T et al (2010) Contribution of dopamine D1 and D2 receptors to amygdala activity in human. J Neurosci 30:3043\u20133047. https:\/\/doi.org\/10.1523\/JNEUROSCI.5689-09.2010","journal-title":"J Neurosci"},{"key":"2180_CR52","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/358149a0","volume":"358","author":"HHM Van Tol","year":"1992","unstructured":"Van Tol HHM, Wu CM, Guan HC, Ohara K, Bunzow JR, Civelli O et al (1992) Multiple dopamine D4 receptor variants in the human population. Nature 358:149\u2013152. https:\/\/doi.org\/10.1038\/358149a0","journal-title":"Nature"},{"key":"2180_CR53","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/s0968-0004(97)01122-5","volume":"22","author":"A Varshavsky","year":"1997","unstructured":"Varshavsky A (1997) The ubiquitin system. Trends Biochem Sci 22:383\u2013387. https:\/\/doi.org\/10.1016\/s0968-0004(97)01122-5","journal-title":"Trends Biochem Sci"},{"key":"2180_CR54","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/onc.2009.314","volume":"29","author":"IR Watson","year":"2010","unstructured":"Watson IR, Li BK, Roche O, Blanch A, Ohh M, Irwin MS (2010) Chemotherapy induces NEDP1-mediated destabilization of MDM2. Oncogene 29:297\u2013304. https:\/\/doi.org\/10.1038\/onc.2009.314","journal-title":"Oncogene"},{"key":"2180_CR55","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1083\/jcb.200610154","volume":"177","author":"BL Wolfe","year":"2007","unstructured":"Wolfe BL, Marchese A, Trejo JA (2007) Ubiquitination differentially regulates clathrin-dependent internalization of protease-activated receptor-1. J Cell Biol 177:905\u2013916. https:\/\/doi.org\/10.1083\/jcb.200610154","journal-title":"J Cell Biol"},{"key":"2180_CR56","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s11060-009-0107-y","volume":"99","author":"ZB Wu","year":"2010","unstructured":"Wu ZB, Zheng WM, Su ZP, Chen Y, Wu JS, Wang CD et al (2010) Expression of D2RmRNA isoforms and ERmRNA isoforms in prolactinomas: correlation with the response to bromocriptine and with tumor biological behavior. J Neuro-Oncol 99:25\u201332. https:\/\/doi.org\/10.1007\/s11060-009-0107-y","journal-title":"J Neuro-Oncol"},{"key":"2180_CR57","doi-asserted-by":"publisher","first-page":"4624","DOI":"10.1038\/s41467-018-06853-3","volume":"9","author":"ZR Wu","year":"2018","unstructured":"Wu ZR, Yan L, Liu YT, Cao L, Guo YH, Zhang Y et al (2018) Inhibition of mTORC1 by lncRNA H19 via disrupting 4E-BP1\/Raptor interaction in pituitary tumours. Nat Commun 9:4624. https:\/\/doi.org\/10.1038\/s41467-018-06853-3","journal-title":"Nat Commun"},{"key":"2180_CR58","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1210\/en.2013-1061","volume":"154","author":"K Yacqub-Usman","year":"2013","unstructured":"Yacqub-Usman K, Duong CV, Clayton RN, Farrell WE (2013) Preincubation of pituitary tumor cells with the epidrugs zebularine and trichostatin a are permissive for retinoic acid-augmented expression of the BMP-4 and D2R genes. Endocrinology 154:1711\u20131721. https:\/\/doi.org\/10.1210\/en.2013-1061","journal-title":"Endocrinology"},{"key":"2180_CR59","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/s41419-018-0805-5","volume":"9","author":"L Yang","year":"2018","unstructured":"Yang L, Wang B, Zhou Q, Wang Y, Liu X, Liu Z et al (2018) MicroRNA-21 prevents excessive inflammation and cardiac dysfunction after myocardial infarction through targeting KBTBD7. Cell Death Dis 9:769. https:\/\/doi.org\/10.1038\/s41419-018-0805-5","journal-title":"Cell Death Dis"},{"key":"2180_CR60","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.canlet.2019.05.043","volume":"459","author":"H Yao","year":"2019","unstructured":"Yao H, Tang H, Zhang Y, Zhang QF, Liu XY, Liu YT et al (2019) DEPTOR inhibits cell proliferation and confers sensitivity to dopamine agonist in pituitary adenoma. Cancer Lett 459:135\u2013144. https:\/\/doi.org\/10.1016\/j.canlet.2019.05.043","journal-title":"Cancer Lett"},{"key":"2180_CR61","doi-asserted-by":"publisher","first-page":"2376","DOI":"10.1172\/JCI97924","volume":"128","author":"J Yu","year":"2018","unstructured":"Yu J, Qin B, Moyer AM, Nowsheen S, Liu T, Qin S et al (2018) DNA methyltransferase expression in triple-negative breast cancer predicts sensitivity to decitabine. J Clin Invest 128:2376\u20132388. https:\/\/doi.org\/10.1172\/JCI97924","journal-title":"J Clin Invest"},{"key":"2180_CR62","doi-asserted-by":"publisher","first-page":"E6418","DOI":"10.1073\/pnas.1614467113","volume":"113","author":"Z Zhang","year":"2016","unstructured":"Zhang Z, Turer E, Li X, Zhan X, Choi M, Tang M et al (2016) Insulin resistance and diabetes caused by genetic or diet-induced KBTBD2 deficiency in mice. Proc Natl Acad Sci USA 113:E6418\u2013E6426. https:\/\/doi.org\/10.1073\/pnas.1614467113","journal-title":"Proc Natl Acad Sci USA"},{"key":"2180_CR63","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3171\/jns.2006.104.1.54","volume":"104","author":"BW Zhe","year":"2006","unstructured":"Wu ZB, Yu CJ, Su ZP, Zhuge QC, Wu JS, Zheng WM (2006) Bromocriptine treatment of invasive giant prolactinomas involving the cavernous sinus: Results of a long-term follow up. J Neurosurg 104:54\u201361.\u00a0https:\/\/doi.org\/10.3171\/jns.2006.104.1.54","journal-title":"J Neurosurg"}],"container-title":["Acta Neuropathologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-020-02180-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00401-020-02180-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-020-02180-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,21]],"date-time":"2021-06-21T23:46:43Z","timestamp":1624319203000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00401-020-02180-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,22]]},"references-count":63,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["2180"],"URL":"https:\/\/doi.org\/10.1007\/s00401-020-02180-4","relation":{},"ISSN":["0001-6322","1432-0533"],"issn-type":[{"value":"0001-6322","type":"print"},{"value":"1432-0533","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,22]]},"assertion":[{"value":"8 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have declared that no conflict of interest exists.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}